0.5974
price up icon3.00%   0.0174
after-market Handel nachbörslich: .59 -0.0074 -1.24%
loading

Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten

pulisher
May 22, 2026

GNTA Stock Price, Quote & Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill

May 22, 2026
pulisher
May 19, 2026

Genenta Science Ends Ospedale San Raffaele License to Refocus Strategy - TipRanks

May 19, 2026
pulisher
May 13, 2026

GNTA Stock Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill

May 13, 2026
pulisher
Apr 28, 2026

Genenta Science to close US subsidiary and transition CFO to consulting role - Investing.com Canada

Apr 28, 2026
pulisher
Apr 28, 2026

Genenta Science to close US subsidiary and transition CFO to consulting role By Investing.com - Investing.com South Africa

Apr 28, 2026
pulisher
Apr 28, 2026

Genenta Science to Close U.S. Subsidiary and Shift CFO to Consulting Role - TipRanks

Apr 28, 2026
pulisher
Apr 24, 2026

Genenta Science Moves Into Aerospace With Majority Investment Deal for Sòphia High Tech - The Globe and Mail

Apr 24, 2026
pulisher
Apr 23, 2026

Genenta signs Definitive Agreements with Sophia High Tech - GlobeNewswire Inc.

Apr 23, 2026
pulisher
Apr 15, 2026

Genenta Science Warned by Nasdaq Over Minimum Bid Price Compliance - The Globe and Mail

Apr 15, 2026
pulisher
Apr 14, 2026

Genenta Science receives Nasdaq notice on minimum bid price compliance By Investing.com - Investing.com India

Apr 14, 2026
pulisher
Apr 14, 2026

Genenta Science receives Nasdaq notice on minimum bid price compliance - Investing.com

Apr 14, 2026
pulisher
Mar 27, 2026

What's going on in today's pre-market session - chartmill.com

Mar 27, 2026
pulisher
Mar 27, 2026

Genenta Moves to Acquire Control of Italian Space-Defense Supplier Sòphia High Tech - TipRanks

Mar 27, 2026
pulisher
Mar 25, 2026

Genenta Science Cancels Late-March Vote on Rebrand to Saentra Forge - The Globe and Mail

Mar 25, 2026
pulisher
Mar 22, 2026

Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX) - The Globe and Mail

Mar 22, 2026
pulisher
Mar 15, 2026

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail

Mar 15, 2026
pulisher
Feb 27, 2026

Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business - Finviz

Feb 27, 2026
pulisher
Feb 27, 2026

11 Best Italian Stocks to Buy in 2026 - Insider Monkey

Feb 27, 2026
pulisher
Feb 21, 2026

Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail

Feb 21, 2026
pulisher
Feb 15, 2026

Genenta Science Piv A Strategic Shift from Biotech to Defense - AD HOC NEWS

Feb 15, 2026
pulisher
Feb 01, 2026

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Aprea Therapeutics (APRE) - The Globe and Mail

Feb 01, 2026
pulisher
Jan 28, 2026

Genenta Science stock soars on strategic pivot to defense sector By Investing.com - Investing.com Australia

Jan 28, 2026
pulisher
Jan 27, 2026

Genenta Science stock soars on strategic pivot to defense sector - Investing.com

Jan 27, 2026
pulisher
Jan 27, 2026

Genenta to Rebrand as Saentra Forge and Pivot into Italian National-Security Industrial Consolidator - TipRanks

Jan 27, 2026
pulisher
Dec 28, 2025

Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and BioLife Solutions (BLFS) - The Globe and Mail

Dec 28, 2025
pulisher
Dec 16, 2025

Genenta Science (NASDAQ:GNTA) Trading Up 0.7% – Here’s What Happened - Defense World

Dec 16, 2025
pulisher
Dec 14, 2025

Operating cash flow per share of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView — Track All Markets

Dec 14, 2025
pulisher
Dec 06, 2025

Return on equity % of Genenta Science SpA Sponsored ADR – LSX:A3C9EK - TradingView

Dec 06, 2025
pulisher
Nov 27, 2025

Healthy Upside Potential: Genenta Science SpA ADR (GNTA) - Setenews

Nov 27, 2025
pulisher
Nov 25, 2025

Genenta Science stock soars after update on glioblastoma treatment study By Investing.com - Investing.com Australia

Nov 25, 2025
pulisher
Nov 24, 2025

Genenta Science stock soars after update on glioblastoma treatment study - Investing.com

Nov 24, 2025
pulisher
Nov 22, 2025

Genenta Science (NASDAQ:GNTA) Shares Down 3.4% – Should You Sell? - Defense World

Nov 22, 2025
pulisher
Nov 10, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Nov 10, 2025
pulisher
Nov 09, 2025

Analysts Are Bullish on These Healthcare Stocks: Altimmune (ALT), Dogwood Therapeutics (DWTX) - The Globe and Mail

Nov 09, 2025
pulisher
Oct 29, 2025

Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - inkl

Oct 29, 2025
pulisher
Oct 28, 2025

Genenta Science Secures $15 Million in Registered Direct Offering - TipRanks

Oct 28, 2025
pulisher
Oct 27, 2025

Genenta Science Appoints New Board Member and Confirms CEO - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

These stocks are moving in today's pre-market session - ChartMill

Oct 27, 2025
pulisher
Oct 26, 2025

Genenta Science Soars Following Strategic Collaboration with Anemocyte - StocksToTrade

Oct 26, 2025
pulisher
Oct 25, 2025

Genenta Science Stock Skyrockets After Strategic Collaboration Announcement - StocksToTrade

Oct 25, 2025
pulisher
Oct 24, 2025

Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill

Oct 24, 2025
pulisher
Oct 04, 2025

Leadership Change at Genenta Science SpA: Dr. Galimi Appointed Acting CMO - The Globe and Mail

Oct 04, 2025
pulisher
Sep 20, 2025

Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), AnaptysBio (ANAB) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail

Sep 20, 2025
pulisher
Sep 10, 2025

Genenta Science S.p.A. Announces Shareholders’ Meeting for Strategic Amendments - TipRanks

Sep 10, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Financing to Boost Cancer Therapy Development - TipRanks

Mar 19, 2025
pulisher
Jan 09, 2025

Genenta Science announces amendment to pact with AGC Biologics - TipRanks

Jan 09, 2025
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):